Literature DB >> 26971263

Antimicrobial prophylaxis to prevent surgical site infection in adolescent idiopathic scoliosis patients undergoing posterior spinal fusion: 2 doses versus antibiotics till drain removal.

Vijay H D Kamath1, Jason Pui Yin Cheung2, Kin Cheung Mak1, Yat Wa Wong1, Wai Yuen Cheung1, Keith Dip Kei Luk1, Kenneth Man Chee Cheung1.   

Abstract

PURPOSE: There is much variation in the choice, timing and duration of antimicrobial prophylaxis for preventing surgical site infections (SSI) but no guideline exists for scoliosis surgery. The aim of study was to compare the efficacy of two antimicrobial prophylaxis (AMP) protocols with cephazolin in preventing SSI in adolescent idiopathic scoliosis (AIS).
METHODS: A retrospective comparative analysis of two post-operative AMP protocols (two postoperative doses versus continued antibiotics till drain removal) was performed. Patient characteristics, pre-operative, intra- and post-operative risk factors for infection, drain use, generic drug name and number of doses administered were recorded from 226 patients with AIS who had undergone posterior spinal fusion. Details of superficial or deep SSI and wound healing aberrations, and serious adverse events were recorded. Analysis was performed to evaluate differences in the pre-, intra- and post-operative variables between the two groups.
RESULTS: 155 patients received 2 postoperative doses of AMP and 71 patients had antibiotics till drain removal. The average follow-up was 43 months. The overall rate of SSI was 1.7 % for the spine wound and 1.3 % for the iliac crest wound. 1.9 % of patients with 2 doses of AMP and 1.4 % of patients with antibiotics till drain removal had SSI. No adverse reactions attributable to cephazolin were observed.
CONCLUSIONS: This is the first study on the AMP protocol in scoliosis surgery for SSI prevention. Results suggest that two doses of AMP are as effective as continued antimicrobial use until drain removal. Cephazolin appears to be effective and safe for prophylaxis.

Entities:  

Keywords:  Adolescent idiopathic scoliosis; Antimicrobial prophylaxis; Posterior spinal fusion

Mesh:

Substances:

Year:  2016        PMID: 26971263     DOI: 10.1007/s00586-016-4491-7

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  40 in total

1.  Perioperative complications of posterior lumbar decompression and arthrodesis in older adults.

Authors:  Leah Y Carreon; Rolando M Puno; John R Dimar; Steven D Glassman; John R Johnson
Journal:  J Bone Joint Surg Am       Date:  2003-11       Impact factor: 5.284

2.  Efficacy of prophylactic antibiotic therapy in spinal surgery: a meta-analysis.

Authors:  Martin H Savitz; Leonard I Malis; Sean I Savitz
Journal:  Neurosurgery       Date:  2003-07       Impact factor: 4.654

3.  Postoperative antimicrobial prophylaxis following spinal decompression surgery: is it necessary?

Authors:  Hiroyuki Kakimaru; Michihaya Kono; Masahiko Matsusaki; Atsushi Iwata; Yuji Uchio
Journal:  J Orthop Sci       Date:  2010-06-18       Impact factor: 1.601

4.  Single-dose vs multiple-dose antibiotic prophylaxis in instrumented lumbar fusion--a prospective study.

Authors:  Leslie C Hellbusch; Michele Helzer-Julin; Stephen E Doran; Lyal G Leibrock; Douglas J Long; Mark J Puccioni; William E Thorell; John S Treves
Journal:  Surg Neurol       Date:  2008-01-18

5.  Postoperative spinal wound infection: a review of 2,391 consecutive index procedures.

Authors:  M A Weinstein; J P McCabe; F P Cammisa
Journal:  J Spinal Disord       Date:  2000-10

6.  Prophylactic parenteral cephalosporins in surgery. Are the newer agents better?

Authors:  J T DiPiro; T A Bowden; V H Hooks
Journal:  JAMA       Date:  1984-12-21       Impact factor: 56.272

7.  [Infections in surgery of idiopathic scoliosis].

Authors:  R Grosman; O Vlach; M Leznar
Journal:  Acta Chir Orthop Traumatol Cech       Date:  2002       Impact factor: 0.531

8.  Perioperative prophylactic cephazolin in spinal surgery. A double-blind placebo-controlled trial.

Authors:  E Rubinstein; G Findler; P Amit; I Shaked
Journal:  J Bone Joint Surg Br       Date:  1994-01

Review 9.  The use of antibiotics for wound prophylaxis in spinal surgery.

Authors:  R L Rimoldi; W Haye
Journal:  Orthop Clin North Am       Date:  1996-01       Impact factor: 2.472

10.  Investigations of the bacteriologic factors in cervical disk surgery.

Authors:  S I Savitz; L V Lee; H B Goldstein; M H Savitz
Journal:  Mt Sinai J Med       Date:  1994-05
View more
  6 in total

1.  Postdischarge antibiotic use for prophylaxis following spinal fusion.

Authors:  David K Warren; Katelin B Nickel; Jennifer H Han; Pam Tolomeo; Christopher J Hostler; Katherine Foy; Ian R Banks; Victoria J Fraser; Margaret A Olsen
Journal:  Infect Control Hosp Epidemiol       Date:  2020-05-05       Impact factor: 3.254

2.  Does Staphylococcus aureus nasal decontamination affect the rate of early surgical site infection in adolescent idiopathic scoliosis surgery?

Authors:  Cindy Mallet; Marion Caseris; Catherine Doit; Anne-Laure Simon; Daphné Michelet; Chrystel Madre; Keyvan Mazda; Stéphane Bonacorsi; Brice Ilharreborde
Journal:  Eur Spine J       Date:  2018-08-25       Impact factor: 3.134

Review 3.  Preoperative measures to prevent/minimize risk of surgical site infection in spinal surgery.

Authors:  Nancy E Epstein
Journal:  Surg Neurol Int       Date:  2018-12-11

4.  Comparative short-term outcomes of enhanced recovery after surgery (ERAS) program and non-ERAS traditional care in elderly patients undergoing lumbar arthrodesis: a retrospective study.

Authors:  Zhong-En Li; Shi-Bao Lu; Chao Kong; Wen-Zhi Sun; Peng Wang; Si-Tao Zhang
Journal:  BMC Musculoskelet Disord       Date:  2021-03-17       Impact factor: 2.362

5.  Therapeutic assessment of N-formyl-methionyl-leucyl-phenylalanine (fMLP) in reducing periprosthetic joint infection.

Authors:  J L Hamilton; M F Mohamed; B R Witt; M A Wimmer; S H Shafikhani
Journal:  Eur Cell Mater       Date:  2021-08-26       Impact factor: 3.942

Review 6.  Drains in Spine Surgery for Degenerative Disc Diseases: A Literature Review to Determine Its Usage.

Authors:  Louis Reier; James B Fowler; Mohammad Arshad; Javed Siddiqi
Journal:  Cureus       Date:  2022-03-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.